Skip to main content
Signal8

PR Newswire press releases

Full-text press releases distributed by PR Newswire, newest first. Times are US Eastern.

Source: PR Newswire

  1. Auxly Reports Third Quarter 2026 Results

    $CBWTF

    Auxly Cannabis Group Inc. (TSX: XLY) (OTCQB: CBWTF) ("Auxly" or the "Company"), a leading consumer packaged goods company in the cannabis products market, today released its financial results for the three and nine months ended September 30, 2026. These filings and additional information regarding Auxly are available on SEDAR+ at www.sedarplus.ca.

  2. NG ENERGY ANNOUNCES FILING OF RECORD Q3 2026 FINANCIAL RESULTS

    $GASXF

    NG Energy International Corp. ("NG Energy" or "NGE" or the "Company") (TSX: GASX) (OTCQX: GASXF) is pleased to announce its financial and operating results for the three and nine months ended September 30, 2026. The Company's interim condensed consolidated financial statements and management's discussion and analysis ("MD&A") for the three and nine months ended September 30, 2026, are available on the Company's website (www.ngenergyintl.com) and profile on SEDAR+ (www.sedarplus.ca). The Company's contractual interest in the Maria Conchita and Sinú-9 Blocks is held through its indirect wholly-owned subsidiary, Operadora NG Energy International, S.A. ("Operadora NGE"), a foreign company that operates in Colombia through its registered branch.

  3. enCore Energy Reports Third Quarter 2026 Financial and Operating Results

    $EU

    enCore Energy Corp. (NASDAQ: EU) (TSXV: EU) (the "Company" or "enCore"), America's Clean Energy Company™, today announced its financial and operational results for the three and nine months ended September 30, 2026. Third quarter revenue increased 88% year over year to $16.7 million on higher uranium deliveries and a stronger average realized price, while the Company continued wellfield development at Alta Mesa and Upper Spring Creek ahead of final regulatory authorizations and took steps to reduce costs and align spending with permitting timelines.

  4. METALLA REPORTS STRONG FINANCIAL RESULTS FOR THE THIRD QUARTER OF 2026 AND ANNOUNCES INAUGURAL CASH FLOW FROM CÔTÉ AND LA PARRILLA ROYALTIES

    $MTA

    Metalla Royalty & Streaming Ltd. ("Metalla" or the "Company") (TSXV: MTA) (NYSE American: MTA) announces its operating and financial results for the three and nine months ended September 30, 2026. For complete details of the condensed interim consolidated financial statements and accompanying management's discussion and analysis ("MD&A") for the three and nine months ended September 30, 2026, please see the Company's filings on SEDAR+ (www.sedarplus.ca) or EDGAR (www.sec.gov). Shareholders are encouraged to visit the Company's website at www.metallaroyalty.com.

  5. BlueNotary Ranks No. 157 on the 2026 Inc. 5000, Fueled by Bootstrapped Growth

    BlueNotary, a leading provider of remote online notarization and digital document execution technology, has been ranked No. 157 on the 2026 Inc. 5000, the annual list recognizing America's fastest-growing private companies, with 2042% 3-year growth.

  6. WeaveGrid to Power V1G, V2X Developments with Hyundai and Kia

    WeaveGrid today announced its partnership with Hyundai Motor Group (the Group) for EV smart charging (V1G) and vehicle-to-grid (V2G) services in North America. WeaveGrid will power the platform that connects Hyundai and Kia vehicles with energy services in the United States. The two companies are developing and expanding smart charging and energy services to be available later to drivers through the myHyundai App and Kia Access App.

  7. Araceli Biosciences Welcomes Jeff Swickard as Investor in Its $4.5 Million Financing Round

    Araceli Biosciences, a developer of high-performance cellular imaging platforms for drug discovery, today announced that Jeff Swickard has joined the investors backing the company's recently closed $4.5 million financing round, which is fueling record commercial momentum following two years of outsized growth, where Araceli's revenue is projected to grow six-fold in 2026 from the same period two years ago. Mr. Swickard is excited to support Araceli's work.

  8. Flo Health's Proprietary Perimenopause Symptom Scale (Peri-SS) Validated as a Reliable, Research-Backed Tool for Assessing Perimenopause Symptoms

    A study, "Validation of the Perimenopause Symptom Scale (Peri-SS) for Digital Self-Assessment: Psychometric Evaluation Among U.S. Women Aged 35 to 59 years," published in Menopause, the official journal of The Menopause Society, confirms the reliability of the Perimenopause Symptom Scale (Peri-SS) - a new, game-changing tool developed by scientists at Flo Health, in collaboration with clinicians from the Mayo Clinic, to better and more accurately measure individual perimenopause experience. The simple, 16-item questionnaire can be used in clinical research and integrated into digital platforms to track the various fluctuating symptoms women experience during perimenopause.

  9. Cellebrite Reports Third-Quarter 2026 Results

    $CLBT

    Cellebrite DI Ltd. (NASDAQ: CLBT), a global leader in AI-powered Digital Investigative and Intelligence solutions for the public and private sectors, today announced financial results for the three and nine-months ending September 30, 2026.

  10. Criteo Announces Inclusion in MSCI Global Investable Market Indexes

    $CRTO

    Criteo (NASDAQ: CRTO) ("Criteo" or the "Company"), the global commerce intelligence platform, today announced its inclusion in the MSCI Global Investable Market Indexes. As announced by MSCI, the inclusion will take effect as of the close of November 30, 2026.

  11. Nevoya and Meta Expand Partnership with 25 New Electric Trucks on the I-10 Corridor

    Nevoya, an AI-native electric truckload carrier, today announced a multi-year agreement with Meta that support the deployment of 25 Class 8 battery-electric trucks on the Interstate 10 (I-10) between San Bernardino, California and Phoenix, Arizona. The deal includes bringing online electric trucking charging infrastructure with the 25 deployed trucks' charging matched 100% with renewable energy certificates.

  12. Atlassian Williams F1 Team Protects Competitive Data From Factory to Track with Keeper Security's Zero-Knowledge Architecture

    Keeper Security, the leading provider of zero-trust and zero-knowledge identity security, today announces a new case study with Atlassian Williams F1 Team, detailing how Keeper protects the credentials guarding Williams' race data across a workforce of 1,200 people operating in more than 20 countries each season. Williams generates upwards of one terabyte of telemetry, aerodynamic and simulation data every race weekend. More than 400 sensors on each of the team's FW48 race cars provide a live feed of 30,000 data channels to engineers both at the circuit and at the team's headquarters in Grove, Oxfordshire.

  13. Worker.ai acquires DeltaGen, launches with backing from billionaire Veeam founder Ratmir Timashev

    Worker.ai today announced the acquisition of Techstars-backed DeltaGen and launched its company operating system for small businesses, with backing from Veeam founder Ratmir Timashev. Founded by former private equity operator John Roberts and DeltaGen founder Rene Bystron, Worker is targeting a painful limit on small-business growth: the owner's capacity to keep everything moving.

  14. KS&R Releases The State of Synthetic, a Comprehensive Report on How Synthetic Data Providers Measure Up

    KS&R, a strategic consultancy and marketing research firm, today released The State of Synthetic, an independent evaluation of how faithfully synthetic data reproduces real human responses. The report scores production models from four synthetic data providers using the ECHO Index, KS&R's patent-pending evaluation methodology. The evaluation focuses on sample boosting, in which a model generates new respondents for questions real people have already answered. The executive summary and full report are available to download at www.ksrinc.com/report/the-state-of-synthetic/.

  15. Kazia Therapeutics to Host Virtual Event on December 2, 2026: Advancing a New Frontier in Oncology with a First-in-Class Nuclear PD-L1 Protein Degrader

    $KZIA

    Kazia Therapeutics Limited (NASDAQ: KZIA) ("Kazia" or the "Company"), an oncology-focused biotechnology company developing therapies that selectively reprogram cancer biology, restore anti-tumor immunity and overcome treatment resistance, today announced that it will host a virtual event on Wednesday, December 2, 2026 at 4:00 PM ET featuring management's overview of NDL2, the Company's novel nuclear PD-L1 protein degrader designed to address mechanisms of immunotherapy resistance in advanced solid tumors, with an initial focus on metastatic breast cancer and colorectal cancer. NDL2 represents a potentially first-in-class approach within the emerging field of targeted protein degradation, a therapeutic category with no known nuclear PD-L1 protein degraders currently in clinical development.

  16. Ascidian and Exegenesis Bio Enter Strategic Agreement to Accelerate Development of RNA Exon Editors with Next-Generation AAV Capsids

    Ascidian Therapeutics, a biotechnology company seeking to treat human diseases by rewriting RNA, and Exegenesis Bio, a global gene therapy company with proprietary AI-enabled optimized AAV capsid discovery capabilities, today announced a strategic agreement combining Ascidian's RNA exon editing technology with Exegenesis Bio's capsid engineering and discovery workflows. The partnership enables novel delivery approaches tailored to the specific clinical needs of individual programs. Collaborative scientific work underway will accelerate in vivo data generation and progression toward clinical development for a suite of RNA exon editors targeting devastating diseases.

  17. Barry-Wehmiller Design Group and Kasm Technologies Partner to Bring Controlled Remote Access to the Plant Floor

    Barry-Wehmiller Design Group (BWDG) and Kasm Technologies today announced a partnership that integrates Kasm for OT into DG360, BWDG's customizable OT security managed services platform. The combined solution gives manufacturers precise control and auditability over who connects to production systems, which assets they can reach, and how long that access lasts.

  18. More Than Half of Stablecoin Flow Gravitates to Asia as Region Cements Status as Global Hub for Digital Dollars

    Global payments infrastructure platform Mercuryo has unveiled data that shows the pivotal role stablecoins are now playing across Asia-Pacific (APAC), where the digital tokens accounted for 56.2% of all its crypto purchases amid mushrooming use cases for blockchain-based payments.

  19. Bentaus, an Energy-First NeoCloud, Deploys DriveNets High-Performance AI Fabric with AMD GPUs to Produce AI Tokens with 30% Less Energy

    DriveNets, a leading provider of high-performance AI networking solutions, and Bentaus, an energy-first NeoCloud, today announced a joint solution that drives more tokens from every data center GPU at greater efficiency per watt, and runs the compute as a flexible load, helping solve the power constraint issues of today's grid. Bentaus cut GPU power 30% while keeping 97% of token throughput on its AI cluster running AMD Instinct™ MI325X GPUs, DriveNets AI Fabric and Bentaus Ziani software.

  20. Astrosalva Therapeutics Adds Michael MacLean, Former CFO of Novartis-Acquired Avidity Biosciences, to Strategic Advisory Board

    Astrosalva Therapeutics, Inc. ("Astrosalva") today announced that Michael MacLean, former chief financial officer of Avidity Biosciences, has joined its Strategic Advisory Board, advising co-founders Thomas Wagner and Paul Schmidt on corporate and capital strategy and financial planning. Astrosalva Therapeutics is a privately held, preclinical biotechnology company developing treatments for Alexander disease (AxD) and cerebral adrenoleukodystrophy (cALD).

  21. RADCOM to Participate in 7th Annual Needham Virtual Tech Week: 1x1 Conference

    $RDCM

    RADCOM Ltd. (NASDAQ: RDCM), a leading provider of advanced, intelligent assurance solutions with integrated AI Operations (AIOps) capabilities, today announced that Benny Eppstein, Chief Executive Officer, and Hod Cohen, Chief Financial Officer, will participate in the 7th Annual Needham Virtual Tech Week: 1x1 Conference, taking place November 18-20, 2026.

  22. Maritime Launch Services Appoints Sarah McLean as Chief Operating Officer

    $MAXQF

    Maritime Launch Services Inc. (TSX: MAXQ) (OTCQB: MAXQF) ("Maritime Launch" or the "Company"), developer and operator of Spaceport Nova Scotia, is pleased to announce the appointment of Sarah McLean as Chief Operating Officer (COO).

  23. May Mobility Plans to Bring Autonomous Volkswagen ID. Buzz Vehicles to Global Robotaxi Platforms

    $ECX

    May Mobility, a leading developer of autonomous driving technology for commercial ride-hail, today announced its plan to bring the iconic Volkswagen ID. Buzz to global robotaxi platforms, powered by May Mobility's autonomous driving system. May Mobility targets deployment of more than 10,000 autonomous ID. Buzz vehicles through 2031.

  24. American Cancer Society Updates Prostate Cancer Screening Guideline: Major Changes Include Regular PSA Testing for Average and High-Risk Men

    The American Cancer Society (ACS) today released an updated guideline for prostate cancer screening to help find cancer before it spreads and reduce the risk of dying from the disease. Key changes include a direct recommendation for prostate-specific antigen (PSA)-based screening every two years for average-risk men aged 50-69, with clinicians ensuring patients understand the potential benefits, limitations, and harms before starting screening. Also, ACS recommends annual PSA-based screening beginning at 45 years old for Black men and men with a strong family history of prostate cancer.

  25. Partner Daniel P. O'Toole Awarded Philanthropic Leadership Award at the Cristian Rivera Foundation's 17th Annual Celebrity Gala

    Daniel P. O'Toole, managing partner of Block O'Toole & Murphy, received the Philanthropic Leadership Award at the Cristian Rivera Foundation's 17th Annual Celebrity Gala this past Tuesday night. Since 2009, the Cristian Rivera Foundation (CRF) has been instrumental in the search to find a cure for D.I.P.G., a rare and deadly childhood brain tumor.

  26. The Aaon Group Announces Expansion of Credit Facility to Support Continued Growth

    $AAON

    The Aaon Group (NASDAQ: AAON) ("The Aaon Group" or the "Company"), a leader in high-performance HVAC and thermal management solutions, today announced the refinancing and expansion of its senior credit facility, increasing total borrowing capacity to as much as $1.2 billion from $600 million. The new credit facility extends the Company's debt maturity profile to 2031 and provides enhanced financial flexibility to support strategic growth initiatives, capital investments and supply chain financing.

  27. Castle Biosciences Earns 2026 Top Workplaces Awards Recognizing Its People-First Culture

    $CSTL

    Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced that it has earned regional Top Workplaces awards in Houston, Arizona and Pittsburgh, along with national recognition through the Top Workplaces Healthcare Industry award and eight Top Workplaces Culture Excellence awards. Based on employee feedback, these honors reflect Castle's continued commitment to creating a workplace where people feel valued, supported and connected to a shared purpose.

  28. YYForce (NASDAQ: YFOR) Secures 100+ Outlet Restaurant Staffing Deal Across Singapore

    $YFOR

    YYForce Inc. (NASDAQ: YFOR) ("YYForce" or the "Company"), an AI-enabled frontline workforce, robotics, and facility solutions provider, today announced that its subsidiary, YY Circle Singapore, has entered into an agreement to supply part-time frontline staff across a major quick-service restaurant (QSR) operator's nationwide network of more than 100 outlets in Singapore.

  29. Racura Oncology Presents Bisantrene MYC Data at Frontiers in Cancer Science 2026 Conference

    Racura Oncology Limited (ASX: RAC), a late clinical-stage biopharmaceutical company developing new small molecule-based approaches to cancer treatment focused on silencing MYC gene expression, today announced that new preclinical data on the MYC-directed mechanism of action of (E,E)-bisantrene are being presented as a poster at the Frontiers in Cancer Science (FCS) 2026 Conference, held in Singapore from 11–13 November 2026. The data show that (E,E)-bisantrene is the major active isomer (molecular form) of bisantrene able to stabilize the G-quadruplex in the MYC gene promoter region, leading to reduced MYC gene expression and MYC protein levels.

  30. Bybit Upgrades Trading Infrastructure to Support Deeper Liquidity, Tighter Spreads and Better Execution

    Bybit, the New Financial Platform trusted by more than 80 million users worldwide, has successfully upgraded its trading infrastructure through a cross-country migration from Singapore to Tokyo.

  31. UCB Announces 11 Inaugural Recipients of Annual Hidradenitis Suppurativa Scholarship™

    UCB, a global biopharmaceutical company, today announced 11 recipients of its inaugural UCB Hidradenitis Suppurativa Scholarship, awarding up to $10,000 per recipient to support educational and career goals.

  32. Enterprises Are Paying for AI Twice: Stibo Systems Research Reveals "The Trust Tax"

    Most enterprises have paid for AI once. Now they are paying for it again. Stibo Systems, a global leader in master data management (MDM), today released The Trust Tax, a new research report showing that enterprises are paying a hidden second bill for AI: the validation, reconciliation and rework needed before anyone will act on what AI produces.

  33. BEASLEY BROADCAST GROUP TO REPORT 2026 THIRD QUARTER FINANCIAL RESULTS, HOST CONFERENCE CALL AND WEBCAST ON NOVEMBER 13

    $BBGI

    Beasley Broadcast Group, Inc. (Nasdaq: BBGI) ("Beasley" or the "Company"), a multi-platform media company, announced today that it will report its 2026 third quarter financial results after the market closes on Friday, November 13, 2026. The Company will host a conference call and webcast at 4.30 p.m. ET that morning to review the results.

  34. Bybit Upgrades Trading Infrastructure to Support Deeper Liquidity, Tighter Spreads and Better Execution

    Bybit, the New Financial Platform trusted by more than 80 million users worldwide, has successfully upgraded its trading infrastructure through a cross-country migration from Singapore to Tokyo.

  35. Kazia Therapeutics to Host Virtual Event on December 2, 2026: Advancing a New Frontier in Oncology with a First-in-Class Nuclear PD-L1 Protein Degrader

    $KZIA

    Kazia Therapeutics Limited (NASDAQ: KZIA) ("Kazia" or the "Company"), an oncology-focused biotechnology company developing therapies that selectively reprogram cancer biology, restore anti-tumor immunity and overcome treatment resistance, today announced that it will host a virtual event on Wednesday, December 2, 2026 at 4:00 PM ET featuring management's overview of NDL2, the Company's novel nuclear PD-L1 protein degrader designed to address mechanisms of immunotherapy resistance in advanced solid tumors, with an initial focus on metastatic breast cancer and colorectal cancer. NDL2 represents a potentially first-in-class approach within the emerging field of targeted protein degradation, a therapeutic category with no known nuclear PD-L1 protein degraders currently in clinical development.

  36. INVESTOR NOTICE: Everest Group, Ltd. Investors with Substantial Losses May Seek to Lead Class Action Lawsuit Before December 28, 2026 Deadline - EG

    $EG

    The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Everest Group, Ltd. (NYSE: EG) common stock between February 8, 2024 and October 27, 2025, inclusive (the "Class Period"), have until December 28, 2026 to seek appointment as lead plaintiff of the Everest Group class action lawsuit.  Captioned City of Detroit General Retirement System v. Everest Group, Ltd., No. 26-cv-09448 (S.D.N.Y.), the Everest Group class action lawsuit charges Everest Group as well as certain of Everest Group's top current and former executives with violations of the Securities Exchange Act of 1934.

  37. Avionics Market worth $84.32 billion by 2031 - Exclusive Report by MarketsandMarkets™

    According to MarketsandMarkets™, the avionics market is projected to grow from USD 61.08 billion in 2026 to USD 84.32 billion by 2031 at a CAGR of 6.7%.

  38. /U P D A T E - Wyndham Hotels & Resorts/

    $WH

    High kicks, holiday sparkle and a front-row stay in the heart of Manhattan—this season, Wyndham Rewards is teaming up with the Christmas Spectacular Starring the Radio City Rockettes to bring the magic of Radio City to The Beekman Tower, Trademark Collection by Wyndham. Introducing The Christmas Spectacular Suite by Wyndham Rewards, an exclusive holiday retreat inspired by America's most beloved holiday show.

  39. Reaching Canada's 100 MMtpa Federal Ambition for LNG Exports Would Support C$1 Trillion of Investment and 250,000 Jobs Annually Through 2050, New S&P Global Energy Study Finds

    $SPGI

    Meeting the Canadian government's goal of 100 MMtpa of liquefied natural gas (LNG) exports by 2050 would support nearly a quarter million jobs annually, stimulate nearly C$1 trillion total investment across the LNG value chain and contribute C$888 billion to the country's gross domestic product to 2050, equal to C$50,000 per household, a new comprehensive S&P Global Energy study finds.

  40. Battery Testing Market worth $45.06 billion in 2033 | MarketsandMarkets™

    According to MarketsandMarkets™, the battery testing market is projected to grow from USD 13.03 billion in 2026 and to reach USD 45.06 billion in 2033, at a Compound Annual Growth Rate (CAGR) of 19.4% during the forecast period.

  41. JELD-WEN Announces Change in Late Exchange Consideration in Exchange Offer and Consent Solicitation for Outstanding 4.875% Senior Notes due 2027

    $JELD

    JELD-WEN Holding, Inc. (NYSE: JELD) ("JELD-WEN" or the "Company") today announced a change to the Late Exchange Consideration in the previously announced offer by JELD-WEN, Inc. (the "Issuer") to (x) all Eligible Holders (as defined herein) of the Issuer's outstanding 4.875% Senior Notes due 2027 (the "Old Notes") to exchange (the "Exchange Offer") any and all of the Old Notes for new first lien senior secured notes due 2031 (the "New Notes") and the related solicitation of consents to certain proposed amendments to the indenture governing the Old Notes (the "Consent Solicitation"), and (y) participants in the Exchange Offer to elect to purchase their applicable Pro Rata Portion of up to $410.2 million in aggregate principal amount of the New Notes (the "New Money Offer"), in each case, on the terms and subject to the conditions set forth in the confidential offering memorandum and consent solicitation statement, dated October 28, 2026 (as supplemented or otherwise modified from time to time, the "Offering Memorandum"). Capitalized terms used herein but not defined herein have the meanings assigned in the Offering Memorandum.

  42. GFL Environmental Announces Issuance of 6,219,896 Subordinate Voting Shares on Conversion of Series A Preferred Shares

    $GFL

    GFL Environmental Inc. (NYSE: GFL) (TSX: GFL) ("GFL" or the "Company") today announced that HPS Investment Partners, LLC ("HPS"), on behalf of the holders of the Company's Series A perpetual convertible preferred shares ("Series A Preferred Shares"), has provided notice of conversion of 4,867,006 Series A Preferred Shares for 6,219,896 subordinate voting shares. Following the conversion, no Series A Preferred Shares will remain outstanding. The subordinate voting shares issued on conversion of the Series A Preferred Shares were sold by funds managed by HPS in a block trade, at a price of US$42.73 per share.

  43. Digital Information Resources Announces Launch of WineWalrus.com, Expanding Its Digital Media Portfolio Into the Wine Industry

    Digital Information Resources (DIR), a technology and digital media company that builds, acquires, and operates niche online properties, today announced the launch of WineWalrus.com, a new digital destination dedicated to wine education, exploration, and the culture surrounding one of the world's most celebrated beverages.

  44. Peak 10 Energy Announces $500 Million Acquisition Finance Facility with U.S. Bank

    Peak 10 Energy ("Peak 10"), a Houston-based oil and gas company backed by Legacy Star Capital Partners, today announced the establishment of a strategic financing partnership with U.S. Bank, N.A. ("U.S. Bank"). U.S. Bank created an acquisition finance facility that provides Peak 10 with up to $500 million to fund the acquisition of oil and gas asset packages across the United States that are primarily proved developed producing ("PDP").

  45. Southern Company announces equity units offering

    $SO

    Southern Company (NYSE: SO) today announced it plans to sell 35 million equity units in a public offering. Each equity unit will be issued in a stated amount of $50 ($1.75 billion aggregate stated amount) and will consist of a contract to purchase Southern Company common stock in the future and two 1/40 undivided beneficial ownership interests in remarketable senior notes each having a principal amount of $1,000. Southern Company expects to grant to the underwriters an option to purchase an additional 5 million equity units ($250 million aggregate stated amount) solely for the purpose of covering over-allotments.

  46. A Run of FDA Target Dates Fills the Biotech Calendar From Late November to Year End

    $BBIO$GILD$PRAX$VRTX$VTRS

    Biotech Today News Commentary - The final weeks of 2026 carry a cluster of U.S. Food and Drug Administration (FDA) target action dates for drugmakers. Five companies that issued quarterly results or pipeline updates between Oct. 29 and Nov. 9 have Prescription Drug User Fee Act (PDUFA) dates on record, according to their own releases, that fall between Nov. 27 and Dec. 27, 2026. The applications cover a form of limb-girdle muscular dystrophy, IgA nephropathy, multiple myeloma, acute pain and SCN2A and SCN8A developmental and epileptic encephalopathies. A PDUFA date is a target date for FDA action on an application. It is not a decision, and the outcome of each review is not known in advance. Active Companies from around the markets with current developments this week include: BridgeBio Pharma, Inc. (NASDAQ: BBIO), Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX), Gilead Sciences, Inc. (NASDAQ: GILD), Viatris Inc. (NASDAQ: VTRS), and Praxis Precision Medicines, Inc. (NASDAQ: PRAX).

  47. Cardinal Infrastructure Group Inc. Reports Third Quarter 2026 Results

    $CDNL

    Cardinal Infrastructure Group Inc. (NASDAQ: CDNL) ("Cardinal" or the "Company"), today announced the Company's third quarter and year-to-date 2026 financial results.

Source: PR Newswire

Content provided by PR Newswire. Redistribution, resale or sublicensing is not permitted.

    PR Newswire press releases | Signal8